KVP Capital Advisors »

Compass Therapeutics shares owned by KVP Capital Advisors

Quarter-by-quarter ownership of Compass Therapeutics (CMPX) shares owned by KVP Capital Advisors from 13F filings

Historical chart of KVP Capital Advisors investment in Compass Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Compass Therapeutics held by KVP Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Compass Therapeutics by KVP Capital Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.6M 500k 5.29

More positions owned by KVP Capital Advisors

Terns Pharmaceuticals (TERN)
Praxis Precision Medicines I Com New (PRAX)
Aadi Bioscience (WHWK)
Axsome Therapeutics (AXSM)
Sutro Biopharma Com Shs (STRO)
Protagonist Therapeutics (PTGX)
Erasca (ERAS)
Trevi Therapeutics (TRVI)
Tango Therapeutics (TNGX)
Insmed Com Par $.01 (INSM)
Edgewise Therapeutics (EWTX)
Revolution Medicines (RVMD)
Disc Medicine (IRON)
Mbx Biosciences (MBX)
Savara (SVRA)

View all positions for KVP Capital Advisors

Top funds holding Compass Therapeutics

Tang Capital Management
OrbiMed Advisors
Suvretta Capital Management
Vivo Capital
BlackRock
Vanguard Group
Enavate Sciences GP
BVF
Vanguard Capital Management
State Street Corporation
Adage Capital Partners GP
Deerfield Management Company
Geode Capital Management
Blue Owl Capital Holdings
Rock Springs Capital Management

View all funds holding Compass Therapeutics